Immediate Impact
73 standout
Citing Papers
Ultrasound-Based Micro-/Nanosystems for Biomedical Applications
2024 Standout
Lorlatinib Versus Crizotinib in Patients With Advanced ALK -Positive Non–Small Cell Lung Cancer: 5-Year Outcomes From the Phase III CROWN Study
2024 Standout
Works of Christopher Dakhil being referenced
Prospective clinical evaluation of blood-based tumor mutational burden (bTMB) as a predictive biomarker for atezolizumab (atezo) in 1L non-small cell lung cancer (NSCLC): Interim B-F1RST results.
2018
Primary efficacy results from B-F1RST, a prospective phase II trial evaluating blood-based tumour mutational burden (bTMB) as a predictive biomarker for atezolizumab (atezo) in 1L non-small cell lung cancer (NSCLC)
2018
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Christopher Dakhil | 255 | 190 | 125 | 20 | 374 | |
| Paloma Martín-Martorell | 273 | 180 | 49 | 27 | 410 | |
| Landon C. Brown | 190 | 242 | 87 | 27 | 356 | |
| Xiangying Meng | 218 | 159 | 73 | 31 | 342 | |
| Fawaz Almutairi | 129 | 229 | 113 | 20 | 353 | |
| Angela Chan | 190 | 92 | 76 | 26 | 339 | |
| BC Lembersky | 291 | 169 | 157 | 14 | 437 | |
| Olivier Marpeau | 106 | 104 | 76 | 15 | 438 | |
| Allison Tyler | 189 | 210 | 104 | 22 | 380 | |
| G. Baciarello | 272 | 201 | 75 | 18 | 411 | |
| Adithya Chennamadhavuni | 329 | 116 | 34 | 18 | 420 |
All Works
Loading papers...